Clinical considerations on chronic migraine, pharmacoresistance and refractoriness

ISSN： 1590-1874

Source： Neurological Sciences, Vol.31, Iss.1, 2010-06, pp. : 83-85

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

By Russell Michael

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 135-136

Springer Publishing Company

Access to resources Recommend Favorite

Reply: Clinical trials on onabotulinumtoxinA for the treatment of chronic migraine

By Aurora Sheena Diener Hans-Christoph Dodick David

The Journal of Headache and Pain, Vol. 12, Iss. 2, 2011-04 ,pp. : 137-138

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacoresistance

By Perucca E.

Electroencephalography and Clinical Neurophysiology, Vol. 99, Iss. 4, 1996-10 ,pp. : 388-388

Elsevier

Access to resources Recommend Favorite

Good news for chronic migraine

By Pascual J.

The Journal of Headache and Pain, Vol. 7, Iss. 4, 2006-09 ,pp. : 169-171

Springer Publishing Company

Access to resources Recommend Favorite

Chronic migraine prevention with topiramate

By Peres M. Mercante J. Tanuri F. Nunes M. Zukerman E.

The Journal of Headache and Pain, Vol. 7, Iss. 4, 2006-09 ,pp. : 185-187

Springer Publishing Company

Access to resources Recommend Favorite